Poster Abstract Session:
62. HIV: Management and Clinical Outcomes
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, HIV-STD-TB, Pediatric ID


Presentations:
580
Key Factors for Treatment Changes within One Year after Starting ART in the German ClinSurv Cohort; between 2005 and 2014
Melanie Stecher, MSc. Public Health; Laura Hamacher, MD.; Martin Platten, MD; Philipp Schommers, MD; Clara Lehmann, PD Dr. med.; Leona Dold, MD; Christian Kollan, Data Manager; Daniel Schmidt, MSc; Barbara Gunsenheimer-Bartmeyer, MD; Janne Vehreschild, Prof. Dr. med.
Posters
  • ID-Week 2018 Key Factors for Treatment Changes within One Year after Starting cART in the German ClinSurv Cohort between 2005 and 2017.pdf (834.0 kB)
    • 581
    Do comorbidities and polypharmacy lead to virologic failure in all populations living with HIV?
    Humberto Jimenez, PharmD, BCPS, AAHIVP; Ty Stevens, PharmD; Jin Suh, MD
    Posters
  • Effect of polypharmacy and comorbidities on virologic suppression poster.pdf (422.1 kB)
    • 583
    Demographic Factors and Clinical Outcomes Associated with Mental Health Medication Use in People Living with HIV
    Swati Mathur, MD; Carla Roberts-Toler, MS; Katherine Tassiopoulos, MPH, DSc; Karl Goodkin, MD, PhD; Milena McLaughin, PharmD, MSc, BCPS-AQ ID, AAHIVP; Susan Koletar, M.D., FIDSA; Kristine Erlandson, MD
    584
    Investigation of the Association between Neurocognitive Function and Depression in HIV Infection
    Brigid Mumford, B.S.; Vanessa Pirrone, Ph.D.; C. Virginia O'Hayer, Ph.D.; William Dampier, Ph.D.; Brian Wigdahl, Ph.D.; Caitlin O'Loughlin, B.A.; Maelys Amat, B.S.; Zsofia Szep, MD
    585
    Hospitalization rates and diagnoses vary by age group among persons with HIV (PWH) in 2014-2015
    Julia Fleming, MD; Stephen Berry, MD, PhD; Chararut Somboonwit, MD; Ank E Nijhawan, MD, MPH, MSCS; Richard Moore, MD, MHS, FIDSA; Kelly Gebo, MD, MPH, FIDSA
    Posters
  • JFleming Final.pdf (2.6 MB)
    • 586
    The Aging Epidemic: Virologic Control, Immunologic Recovery, Treatment Regimens, and Clinical Outcomes among Older Adults Living with HIV in Washington, DC.
    Hana Akselrod, MD, MPH; Annette Aldous, MPH; David Parenti, MD, FIDSA; Gary Simon, MD, PhD, FIDSA
    Posters
  • Aging Cohort Poster for ID Week Final.pdf (697.0 kB)
    • 587
    HIV Care Outcomes among PWID in San Francisco, 2009-2015
    Nathan Kim, B.A. in Public Health; Susie Welty, MPH; Tania Reza, MPP; David Sears, MD; Willi McFarland, MD PhD; H. Fisher Raymond, DrPH, MPH
    588
    Retrospective Analysis of Clinical Characteristics and Treatment Patterns Among HIV Patients with Commercial and Medicare Advantage Health Insurance in the US
    Julie Priest, MSPH; Tanya Burton, PhD; Cori Blauer-Peterson, MPH; Katherine Andrade, MPH; Alan Oglesby, MPH
    589
    Assessment of an Antiretroviral Therapy Policy in Patients With Human Immunodeficiency Virus at a Large Academic Medical Center
    Elizabeth Barber, PharmD; Kady Phe, PharmD; Hannah Palmer Russo, PharmD; Mayar Al Mohajer, MD, MBA, CAQ, FACP
    590
    Tackling HIV/AIDS in Brooklyn New York Within a Network of Federally Qualified Health Centers
    Neil Pasco, MD; Finn Schubert, MPH; Jesica Hayon, MD; Tiffany Yi Shan Lee, MD; Anum Aamir, MD; Marilyn Chacko, DO; Isaac Dapkins, MD
    591
    Impact of an antimicrobial stewardship (ASP) initiative evaluating antiretroviral regimens for HIV-positive patients
    Kwabena Nimarko, Pharm.D.; Aiman Bandali, Pharm.D, AAHIVP; Tiffany Bias, PharmD, BCPS, AAHIVP; Sharon Mindel, Pharm.D.
    592
    Determining the Impact of an Antiretroviral Stewardship Team on the Care of HIV-Infected Patients Admitted to an Academic Research Institution
    Ashley DePuy, PharmD; Rafik Samuel, MD, FIDSA; David Koren, PharmD
    Posters
  • Determining the Impact of an Antiretroviral Stewardship Team on the Care of HIV-Infected Patients Admitted to an Academic Research Institution.pdf (270.2 kB)
    • 593
    A Nationwide Assessment of Predictive Factors for Provision of Continuity of Care Resources for HIV-Positive Detainees in ICE Health Service Corps-staffed Facilities, 2015 and 2017
    Alexandra Mishreki, MPH; Stephanie Brodine, MD; Ming Yang, PhD; Edith Lederman, MD, MPH, FIDSA
    Posters
  • IDweekPoster_FINALDRAFT.pdf (585.8 kB)
    • 594
    The Prevention and Management of HIV:Online Education as a Tool to Improve Knowledge and Confidence among HIV/ID Specialists
    Simi Hurst, PhD; Susan Smith, MN, PhD
    Posters
  • Hurst-IDWeek 2018-HIV1_Final.pdf (178.6 kB)
    • 595
    Changes in Ryan White Clinic Referral Patterns among HIV-infected Patients following Implementation of the Affordable Care Act
    Cameron Wade, BS; Justin Yang, MS; Jana Collins, MS; Wayne Sanderson, PhD, MS; Timothy Crawford, PhD, MPH; Alice Thornton, MD, FIDSA
    Posters
  • Changes in referral patterns to link Persons Living with HIV (PLWH) into a Ryan White HIV clinic post Affordable Care Act and Medicaid expansion.pdf (571.7 kB)
    • 596
    Case Study of Motivational Interviewing Intervention in Patients Non-Adherent to Antiretroviral Therapy
    Katherine Brooks, MD; Jennifer Johnson, MD; Susan Larrabee, LICSW; John Grimaldi, MD
    Posters
  • BrooksIDWeekPoster.pdf (1.7 MB)
    • 597
    Pharmacist-led interventions for inpatient HIV-related medication errors
    Mary Joyce B. Wingler, PharmD; Kayla R. Stover, PharmD, BCPS; Katie E. Barber, PharmD; Jamie L. Wagner, PharmD
    Posters
  • IDWeek HIV Poster_FINAL.pdf (598.9 kB)
    • 598
    Choosing Wisely with CD4 Counts: When Less is More
    Don Bambino Geno Tai, MD, MBA; Arlene Yu, MD, MBA; Robert Goldstein, MD, FACP
    Posters
  • Geno_Sep_PrintReady.pdf (4.1 MB)
    • 599
    Expanding HIV Training in Internal Medicine Residency Program: A Prospect to Meet the HIV Workforce Demand
    Lydia Barakat, MD; Dana Dunne, MD; Onyema Ogbuagu, MD, FACP; Michael Green, MD
    Posters
  • Expanding HIV Training in IM Residency Program.pdf (734.9 kB)
    • 600
    To study the status of HIV disclosure in children and adolescents.
    Alok Hemal Sr., M.B.B.S, M.D, CCST(UK); Meetu Singh, MD paediatrics
    601
    Prescription Drug Misuse in an HIV-Infected U.S. Military Cohort
    Robert Deiss, MD; Morgan Byrne, MPH; Derek Larson, DO; Anuradha Ganesan, MD, MPH; Adi Noiman, PhD; Eric Garges, MD, MPH; Kelli Randell, MD; Jason Okulicz, MD; Karl Kronmann, MD, MPH; Christina Schofield, MD FACP, FIDSA; Grace Macalino, PhD; Ryan Maves, MD, FCCP, FIDSA; Brian Agan, MD
    Posters
  • IDCRP HIV 09_27_18 FINAL (002).pdf (478.2 kB)
    • 602
    Factors Associated with Erectile Dysfunction Diagnosis in HIV-infected Individuals: A Case-control Study
    Nathan Jansen, DO; Colton Daniels, MS; T.S. Sunil, PhD, MPS; Xiaohe Xu, PhD, MPS; Jason M. Cota, PharmD, MSc; Morgan Byrne, MPH; Anuradha Ganesan, MD, MPH; Robert Deiss, MD; Brian Agan, MD; Jason Okulicz, MD
    Posters
  • ID Week Poster HIV and ED Sep 25.pdf (113.6 kB)
    • 603
    Multi-morbidity and Impaired CD4/CD8 ratios in Older Adults with well controlled HIV.
    Oluwatoyin Adeyemi, MD; Lisa Diep, MPH
    Posters
  • IDWeek2018 CD4CD8poster.pdf (488.0 kB)
    • 604
    Impact of Substance and Alcohol Abuse on Smoking Related Behaviors When Using a Smoking Cessation Decisional Algorithm Among People Living with HIV (PLWH)
    Madelyne C. Bean, PharmD; Lauren E. Richey, MD, MPH
    Posters
  • IDSA Poster 2018 Final PDF.pdf (443.8 kB)
    • 605
    Loneliness among Older Adults Living with HIV: a Study and Online Community
    Mark Kane, MPH; Peter Mazonson, MD, MBA; Andrew Zolopa, MD; Frank Spinelli, MD, FACP; Pedro Eitz Ferrer, BSc MPH PHD; Peter Shalit, MD, PhD
    Posters
  • ID Week Poster 092418.pdf (464.7 kB)

    • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.